Bal Pharma Limited — Others, 03-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bal Pharma Limited has announced a board meeting on [date] to consider the financial results for the quarter and half-year. The company confirmed timely submission of details related to securities dematerialized and rematerialized during the quarter, based on certificates from its registrar and transfer agents. Share certificates received for dematerialization were duly verified, canceled, and substituted in favor of the depository within the stipulated timeframe. This update reflects Bal Pharma’s compliance with share handling processes, ensuring smooth securities management for shareholders.